Documents

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 October 2024)

Mandate of the ACT EU Steering Group

Meeting highlights - MSP Advisory Group 27 September 2024

MSP Advisory Group Mandate and rules of procedure

Short, medium, long term actions proposed by Industry trade associations

New CTIS Public Portal functionality

Approach to consulting academic stakeholders

Discussion on stakeholder priorities to advise ACT EU Steering Group

Report from CTR Collaborate stakeholder meeting held on 11 September

MSP AG report on the most frequently reported and major issues

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 September 2024)

Member States participating in ACT EU pilots on consolidated advice

Agenda MSP Advisory Group meeting 27 September 2024

Meeting highlights - MSP Advisory Group 4 July 2024

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 August 2024)

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 July 2024)

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 June 2024)

Challenges and possible options when designing a Platform Trial - F. Houyez (EURORDIS)

Challenges in performing mult-country Investigator Initiated Trials in EU - M. Zuidgeest (UMC Utrecht)

CTA review process and CTR implementation - L. Leyens (EFPIA)